6550--Notice of Intent to Sole Source; Qiagen LLC
Veterans Affairs · 242-NETWORK CONTRACT OFFICE 02 (36C242)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24226Q0960 in this department, oldest first.
- Aug 31, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs (DVA) Network Contracting Office NCO2, on behalf of VISN2 South Medical Centers, intends to award a Firm Fixed Price (FFP), sole source action to: Name of Contractor: QIAGEN LLC Street Address: 19300 Germantown Road City, State, Zip: Germantown, MD 20874-1415 VISN02 medical centers have a recurring requirement for US Food & Drug Administration (FDA) approved In Vitro Diagnostic (IVD), cell mediated immunity (IGRA) tests for detecting Mycobacterium infections using chem… (show all)
iluminescence immunoassay (CLIA) on LIAISON analyzers. Market research was conducted in accordance with FAR Part 10, reviewing the offerings and capabilities available through the current marketplace. In accordance with the Revolutionary FAR Overhaul (RFO) Part 6.103-1, it has been determined that only one source is reasonably available, QIAGEN LLC. QIAGEN is the manufacturer and sole distributor of the QuantiFERON TB Gold testing. QuantiFERON is the only test capable of meeting the salient characteristics of the requirement and providing the necessary compatibility with the Department of Veterans Affairs existing LIAISON analyzers. Market research failed to produce additional sources capable of fulfilling this requirement as a whole; No subcontracting opportunities are available for this requirement. In accordance with the Revolutionary FAR Overhaul (RFO) this notice of intent to sole source with justification to limit sources, satisfies the public posting requirements. Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on September 15, 2025. Responses to be submitted to Lindsay Goldsmith, Contracting Officer at lindsay.goldsmith@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (242-NETWORK CONTRACT OFFICE 02 (36C242)), same product/service code (PSC) 6550 and NAICS 325413.
Single-winner award sizes (3): middle half $318K to $654K, median $388K; range $248K to $920K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT MOLECULAR INC. · $ABT · $45.1B | 1 | $920K | Oct 6, 2026 |
| WERFEN USA LLC | 1 | $388K | Oct 1, 2026 |
| 10X GENOMICS, INC. · $TXG · $616.9M | 1 | $248K | Sep 25, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 3 past awards, $388K, is under 0.1% of that. SEC filing
- $TXG reported $616.9M revenue (12 months to Jun 30, 2026). The median single-winner award in these 3 past awards, $388K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 6, 2026ABBOTT MOLECULAR INC.$920K6550--LAB - ABBOTT ALINITY-M PCR MOLECULAR REAGENTS & SUPPLIESMateriality: <0.01% of $ABT revenue (Low) SEC
- Oct 1, 2026WERFEN USA LLC$388K6550--Werfen Immunocor Blood Bank Reagents and Supplies Northport and East OrangeNo listed company matched (Materiality N/A)
- Sep 25, 202510X GENOMICS, INC.$248K6550--SUPPLY - GENE EXPRESSION KITSMateriality: 0.04% of $TXG revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $48K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 5 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.